Literature DB >> 25710

A general mechanism for microsomal activation of quinone anticancer agents to free radicals.

N R Bachur, S L Gordon, M V Gee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 25710

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  80 in total

1.  Porfiromycin disposition in oxygen-modulated P388 cells.

Authors:  S S Pan
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women.

Authors:  Y Cottin; C Touzery; B Coudert; S Richebourg; M Cohen; M Toubeau; P Louis; J E Wolf; F Brunotte
Journal:  Eur J Nucl Med       Date:  1996-05

Review 3.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

4.  Copper salt-catalyzed formation of a novel series of triazole-spirodienone conjugates with potent anticancer activity.

Authors:  Linghui Gu; Peng Wang; Qiu Zhong; Yuxing Deng; Jiangping Xie; Fei Liu; Fan Xiao; Shilong Zheng; Yue Chen; Guangdi Wang; Ling He
Journal:  RSC Adv       Date:  2017-01-30       Impact factor: 3.361

5.  Genotoxicity in the hepatocyte/DNA repair test and toxicity to liver mitochondria of 1-hydroxyanthraquinone and several dihydroxyanthraquinones.

Authors:  K Kawai; H Mori; S Sugie; N Yoshimi; T Inoue; T Nakamaru; Y Nozawa; T Matsushima
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

6.  Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.

Authors:  P Skehan; J Thomas; S J Friedman
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

7.  Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxia.

Authors:  C U Ludwig; Y M Peng; J N Beaudry; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 8.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

9.  Laser flow cytometric studies on the intracellular accumulation of anthracyclines when combined with heat.

Authors:  Y Sakaguchi; Y Maehara; S Inutsuka; I Takahashi; M Yoshida; Y Emi; H Baba; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Semiquinone radicals from oxygenated polychlorinated biphenyls: electron paramagnetic resonance studies.

Authors:  Yang Song; Brett A Wagner; Hans-Joachim Lehmler; Garry R Buettner
Journal:  Chem Res Toxicol       Date:  2008-06-13       Impact factor: 3.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.